The increase of PD-L1 in HNSCC cells with certain characteristics after treatment with palbociclib and arrest in the G1 phase may contribute to a lack of therapeutic response due to the intrinsic carcinogenic mechanisms of PD-L1 overriding cell inhibition. This evidence concerns the gene CD274 and head and neck squamous cell carcinoma.